111 related articles for article (PubMed ID: 25429778)
1. Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody.
García MF; Calzada V; Camacho X; Goicochea E; Gambini JP; Quinn TP; Porcal W; Cabral P
Curr Radiopharm; 2014; 7(2):84-90. PubMed ID: 25429778
[TBL] [Abstract][Full Text] [Related]
2. Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
Surfraz MB; King R; Mather SJ; Biagini SC; Blower PJ
J Med Chem; 2007 Mar; 50(6):1418-22. PubMed ID: 17315986
[TBL] [Abstract][Full Text] [Related]
3. Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Calzada V; García MF; Alonso-Martínez LM; Camachoc X; Goicochea E; Fernández M; Castillo AX; Díaz-Miqueli A; Iznaga-Escobar N; Montaña RL; Alonso O; Gambini JP; Cabral P
Anticancer Agents Med Chem; 2016; 16(9):1184-9. PubMed ID: 26961312
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.
Rennen HJ; Laverman P; van Eerd JE; Oyen WJ; Corstens FH; Boerman OC
Nucl Med Biol; 2007 Aug; 34(6):691-5. PubMed ID: 17707809
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.
Garcia MF; Camacho X; Calzada V; Fernandez M; Porcal W; Alonso O; Gambini JP; Cabral P
Curr Radiopharm; 2012 Jan; 5(1):59-64. PubMed ID: 22074480
[TBL] [Abstract][Full Text] [Related]
7. Labeling polyamidoamine (PAMAM) dendrimers with technetium-99m via hydrazinonicotinamide (HYNIC).
Kovacs L; Tassano M; Cabrera M; Fernández M; Porcal W; Anjos RM; Cabral P
Curr Radiopharm; 2014; 7(2):115-22. PubMed ID: 25175622
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.
Barta P; Laznickova A; Laznicek M; Vera DR; Beran M
J Labelled Comp Radiopharm; 2013 May; 56(5):280-8. PubMed ID: 24285372
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
[TBL] [Abstract][Full Text] [Related]
10. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
11. Direct 99m Tc labeling of Herceptin (trastuzumab) by 99m Tc(I) tricarbonyl ion.
Chen WJ; Yen CL; Lo ST; Chen KT; Lo JM
Appl Radiat Isot; 2008 Mar; 66(3):340-5. PubMed ID: 17996452
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
13. Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes.
Green AE; Causey PW; Louie AS; Armstrong AF; Harrington LE; Valliant JF
Inorg Chem; 2006 Jul; 45(15):5727-9. PubMed ID: 16841972
[TBL] [Abstract][Full Text] [Related]
14. Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Rennen HJ; Boerman OC; Koenders EB; Oyen WJ; Corstens FH
Nucl Med Biol; 2000 Aug; 27(6):599-604. PubMed ID: 11056376
[TBL] [Abstract][Full Text] [Related]
15. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
16. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide.
Edwards DS; Liu S; Harris AR; Poirier MJ; Ewels BA
Bioconjug Chem; 1999; 10(5):803-7. PubMed ID: 10502346
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
Teng B; Bai Y; Chang Y; Chen S; Li Z
Bioorg Med Chem Lett; 2007 Jun; 17(12):3440-4. PubMed ID: 17449246
[TBL] [Abstract][Full Text] [Related]
20. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
